Yakira Capital Management »

Blueprint Medicines shares owned by Yakira Capital Management

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Yakira Capital Management from 13F filings

Historical chart of Yakira Capital Management investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Yakira Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Yakira Capital Management

Quarter filed Position value Share count Share price at filing
2025-06-30 $5.7M 44k 128.18

More positions owned by Yakira Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Gigcapital7 Corp Ord Shs Cl A (GIG)
Cornerstone Total Rtrn Fd In (CRF)
Chart Industries (GTLS)
Verona Pharma Sponsored Ads (VRNA)
Interpublic Group of Companies (IPG)
Kellogg Company (K)
Cornerstone Strategic Value (CLM)
Iac Com New (IAC)
Avidxchange Holdings (AVDX)
Frontier Communications Pare (FYBR)
Liberty Broadband Corp Com Ser A (LBRDA)
ClearBridge Energy MLP Fund (EMO)
Cohen & Steers infrastucture Fund (UTF)
Rf Acquisition Corp Ii Unit 05/01/2026 (RFAIU)

View all positions for Yakira Capital Management

Top funds holding Blueprint Medicines

Morgan Stanley
Taylor Investment Counselors
DekaBank Deutsche Girozentrale
Cibc World Markets
E Fund Management
KBC Group NV
Vega Investment Solutions
Van Eck Associates Corp.
IFP Advisors
Advisor Group Holdings
FTB Advisors
Huntington National Bank

View all funds holding Blueprint Medicines